Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with the same mutation, a rare finding of a direct genetic link to psychosis, ...
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback